These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 34071499)

  • 61. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Polycystic ovary syndrome, obesity and reproductive implications.
    Hirschberg AL
    Womens Health (Lond); 2009 Sep; 5(5):529-40; quiz 541-2. PubMed ID: 19702452
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of hyperinsulinaemia and insulin resistance on endocrine, metabolic and fertility outcomes in women with polycystic ovary syndrome undergoing ovulation induction.
    Zhang D; Yang X; Li J; Yu J; Wu X
    Clin Endocrinol (Oxf); 2019 Sep; 91(3):440-448. PubMed ID: 31222771
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.
    Ibáñez L; Oberfield SE; Witchel S; Auchus RJ; Chang RJ; Codner E; Dabadghao P; Darendeliler F; Elbarbary NS; Gambineri A; Garcia Rudaz C; Hoeger KM; López-Bermejo A; Ong K; Peña AS; Reinehr T; Santoro N; Tena-Sempere M; Tao R; Yildiz BO; Alkhayyat H; Deeb A; Joel D; Horikawa R; de Zegher F; Lee PA
    Horm Res Paediatr; 2017; 88(6):371-395. PubMed ID: 29156452
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Insulin-lowering agents in the management of polycystic ovary syndrome.
    De Leo V; la Marca A; Petraglia F
    Endocr Rev; 2003 Oct; 24(5):633-67. PubMed ID: 14570747
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
    Spritzer PM
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study.
    Advani K; Batra M; Tajpuriya S; Gupta R; Saraswat A; Nagar HD; Makwana L; Kshirsagar S; Kaul P; Ghosh AK; Pradhan S; Mehta A; Jaiswal A; Nakhate KT; Kamdi S
    J Obstet Gynaecol; 2020 Jan; 40(1):96-101. PubMed ID: 31339394
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnosis and management of polycystic ovary syndrome: a practical guide.
    Stankiewicz M; Norman R
    Drugs; 2006; 66(7):903-12. PubMed ID: 16740005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Insulin resistance, polycystic ovary syndrome and metformin.
    Pugeat M; Ducluzeau PH
    Drugs; 1999; 58 Suppl 1():41-6; discussion 75-82. PubMed ID: 10576524
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
    Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
    J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.
    De Leo V; Musacchio MC; Palermo V; Di Sabatino A; Morgante G; Petraglia F
    Drugs Today (Barc); 2009 Oct; 45(10):763-75. PubMed ID: 20069140
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management.
    Farshchi H; Rane A; Love A; Kennedy RL
    J Obstet Gynaecol; 2007 Nov; 27(8):762-73. PubMed ID: 18097891
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndrome.
    Bicer M; Alan M; Alarslan P; Guler A; Kocabas GU; Imamoglu C; Aksit M; Bozkaya G; Isil AM; Baloglu A; Aslanipoiur B; Calan M
    J Endocrinol Invest; 2019 Mar; 42(3):303-312. PubMed ID: 29956214
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.
    Rosenfield RL
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):412-9. PubMed ID: 25840648
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents.
    Rahmanpour H; Jamal L; Mousavinasab SN; Esmailzadeh A; Azarkhish K
    J Pediatr Adolesc Gynecol; 2012 Jun; 25(3):208-12. PubMed ID: 22578482
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation.
    Asagami T; Holmes TH; Reaven G
    Metabolism; 2008 Oct; 57(10):1355-60. PubMed ID: 18803938
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Polycystic Ovary Syndrome in Adolescents.
    Witchel SF; Roumimper H; Oberfield S
    Endocrinol Metab Clin North Am; 2016 Jun; 45(2):329-44. PubMed ID: 27241968
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
    Jiskoot G; Benneheij SH; Beerthuizen A; de Niet JE; de Klerk C; Timman R; Busschbach JJ; Laven JS
    Reprod Health; 2017 Mar; 14(1):34. PubMed ID: 28264692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.